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i, INTRODUCTION 
We have recently identified a new protein kinase in 
rabbit skeletal muscle which is only active after it has 
been phosphorylatcd on a unique threonine residue by 
mitogen-activated protein kinase (MAP kinase) [1]. 
This enzyme, which has been termed MAP kinase acti- 
vated ]2rotein kinase-2 (MAPKAP kinase-2) can be-dis- 
tinguished from $6 kinase-II (or MAPKAP kinase-l) 
[2], the only other protein kinase known to be activated 
by MAP kinase, by its response to inhibitors, failure to 
phosphorylate p ptides related to the C-temlinus of ri- 
bosomal protein $6 and by its amino acid sequence [1]. 
MAPKAP kinase-2 was originally identified by its abil- 
ity to phosphorylat¢ rabbit skeletal muscle gl~.'ogen 
synthase, which it labels preferentially on a serine lo- 
cated seven residues from the N-terminus. It also phos- 
phorylates the first serine in the peptide KKPLNRTLS- 
VASLPGLamide, which is related to the N-terminus of 
glycogen synthase, and this substrate is used to assay 
MAPKAP kinase-2 routinely [I], 
Although glycogen synthase was the first substrate 
for MAPKAP kinase-2 to be identified, it is not clear 
whether it is phosphorylated by this protein kinase in 
vice, Furthermore, since MAPKAP kinase-i may phos- 
phorylate more than one substrate in vice (e.g. the gly- 
cogen-bindin 8 subunit of protein phosphatase-1 [3]and 
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ribosomal protein $6 [4]), MAPKAP kinme-2 may aim 
have a number of physiological substmtes and thereby 
mediate veral actions of extraodlular dSuab which 
exert their effects through the activation of MAP idmu~ 
and its downstream targets. We were lh¢~occ inter- 
ested in identifying potential ph)~olosical subslrates 
for MAPKAP kinase-2. 
Murine heat shock protein ~ (hsp25) and its human 
homologue heat shock protein 27 (hsp27) are small 
thermostable proteins present in almost all nmmmalian 
cells, which become phosphorylated in many cells in 
response to signals such as tumour necrosis factor 
(TNF) [5,6], intedeuk,.'n-I [6,7], platelet derived growth 
factor (PDGF) [7] and fibroblast growth factor (FGF) 
[7,8], as well as turnout-promoting phorboi esters [9,10| 
and •heat shock [1 I--13], Their physiological roles are 
unknown, although overexpression f hsp27 and hsp25 
has been reported to increase the thermotoleranceof 
some mammalian cells [14.15] and to inhibit cell prolif- 
eration [15|. Our interest in examining whether hsp25 
and hsp27 x~re ph3-~ioiogical substrates for MAPKAP 
kinase-2 was amused by two observations. Firstly, sev- 
eral of the stimuli which trigger the phosphorylation f 
hsp25 and hsp27 in cells, such as PDGF, phorboi esters 
and heat shock, are known to activate MAP kinase 
[16,17]. Secondly, the amino acid sequences surround- 
ing one of the in vice phosphorylation sites in hopes 
(LNRQLSSG) jig] or hsp27 (LSRQLSSG) [g] are ver~ 
similar to the sequence surrounding sc.-ine-7 of glycogen 
synthase in human (LNRTLSVS) [19] or rabbit 
(LSRTLSVS) [20] skeletal muscle. In this paper we dem- 
onstrate that MAPKAP kinase-2 (but not MAPKAP 
kinase-I) phosphorylates ach of the serine residues in 
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Fig. 1. Phosphorylation f hsp25 (A) and hsp27 (B) by MAPKAP kinase-2. Phosphorylation f hsp25 and hsp27 (50/zM) was carried out with 
2 U/ml MAPKAP klnase.2 as described in Section 2. Calculation of phosphorylation stoiehiometries was based on molecular masses of 25 kDa 
(hsp25) and 27 kDa (hsp27) and protein concentrations measured according to Bradford [30]. Values obtained by the Bradford procedure agreed 
with those obtained by amino acid analysis to :I: 10%. Phosphate incorporated into hsp25 or hsp27 is denoted by the closed circles. Phosphorylation 
of Ser t~ (S-15, V) and Ser ~ (S.86, O) of hsp25 and Set Is, Set TM (S-78, T~') and Set ~'~ (S-82, O) of hsp27 was determined by measul'ement of the 
nP-radioactivlty associated with the tryptic peptides containing each of these residues (Figs. 2 and 4). 
hsp25 and hsp27 that are phosphorylated in rive in 
response to mitogens or heat shock, that hsp25 kinase 
activity co-purifies with MAPKAP kinase-2 throughout 
the purification of the latter enzyme and that MAPKAP 
kinase-2 and the substrata small heat shock protein are 
co-expressed in rabbit skeletal muscle. These results 
strongly suggests hat MAPKAP kinase-2 is an enzyme 
responsible for phosphorylating hsp25 and hsp27 in 
vivo. 
2. MATERIALS AND METHODS 
MAPKAP kinase-2 [1], recombinant marine hsp25 [21] and recom- 
binant hsp27 [22] were purified as described. MAPKAP kinase-I (Mr. 
C. Satherland) [23] and the catalytic subunit of protein phosphatase 
2A (Dr. D. Schelling) [24] were purified from rabbit skeletal muscle 
at Dundee by the investigators in parentheses. Calmodalin-dependent 
protein kinase-ll from rat brain was provided by Dr. Angus Nairn 
(Rockefeller University, New York, USA). Phosphorylation f the 
standard peptide substrata KKPLNRTLSVASLPGLamide by 
MAPKAP kinase-2 and other protein kinases was carried out in the 
presence of EGTA, the specific peptide inhibitor of cyclic AMP-de- 
pendent protein kinase and the protein kinase inhibitor H7 (which 
does not inhibit MAPKAP kinase-2) as described [1] and one unit of 
activity (U) was that amount which catalysed the phosphorylation f 
one nmol of peptide in one rain. When hsp25 and hsp27 were used as 
substrat~s, reactions were terminated by addition of 1.0 ml of S% (w/v) 
trlehloroacetie acid. After standing for 5 rain, the suspensions were 
centrifuged for 2 rain at 13,000 × g and the supernatants discarded. 
The pellets were washed tltrc~ times with 25% (w/v) trichloroac~tic 
acid and analysed by Cerenkov counting. Phosphorylation of the 
small heat shock protein by purified MAPKAP kinase.2 was carried 
out in rabbit muscle xtracts heated at 42°C for 10 min to inactivate 
protein kinases. The incubations were carri~xl out at 30°C with 5 mM 
MgCI,/0.1 mM [7-nP]ATP (0.1 Cihnmol), with and without 0.5 U/ml 
MAPKAP kinase-2, and after 30 rain the small heat shock protein wm 
immunoprecipitated with 10/zl of an antiserum against an hsp25/ 
hsp27 hybrid protein which cro~s-reacts between different mammalian 
species [25]. After secondary precipitation using Protein A-Sepharose 
(Pbarmacia), proteins bound specifically were elated by heatin 8 at 
100°C in the presence of SDS, subjected to SDS/polyaarylamide gel 
electrophoresis and autoradiographed using a Bin Imaging Analyser 
BAS 2000 (Fuji). Amino acid analysis was carried out using a Waters 
PICOTAG System. Other materials and methods are detailed in [1]. 
3, RESULTS 
3.1. PhosphotTlation f hsp25 and hsp27 by MAPKAP 
kinase-2 
hsp25 and hsp 27 were both phosphorylated by 
MAPKAP kinase-2 at similar rates to the standard pep- 
tide substrata KKPLNRTLSVASLPGLamide. The ini- 
tial rate of phosphorylation of hsp25 (20/~M) was 55% 
o£ the rate at which the peptide substrata (30/zM) was 
phosphorylated. The K., for hsp25 phosphor2clation (19 
~tM) was also similar to that of the peptide substrata (12 
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Fig. 2, Separation of ~-'P-labelled tryptic peptides from hsp25 by 
chromatography on a C~n column. The trichloroacetic acid precipi- 
tated hsp25 from the 15 rain (upper trace) and 135 rain (lower trace) 
time points in Fig. IA (2.5 nmol) were digested with trypsin (2/ag, 0.08 
nmol) and ehromatographgd on a Vydac Ct~ reverse phase HPLC 
column (Separations Group, Hesperia, California, USA) equilibrated 
in 0.1% (v/v) trifluoroacetic acid, as described previously [1]. ~P- 
radioactivity (full line) wa~ recorded continuously with an on-line 
monitor. The acetonitril¢ gradient is shown by the broken line. The 
analysi.~ of peptides la and lb (containing Ser~°), and 2a, 2b and 2c 
(containing Ser iS) is presented in Section 3.2. 
/aM). hsp27 was phosphorylated at about half the rate 
of hsp25 (Fig. 1). The pho sphorylation ofhsp25 reached 
1.7 tool/tool and the phosphorylation f hsp27 1.0 tool/ 
tool after incubation for 2 h with 2 U/ml MAPKAP 
kinase-2. In contrast, MAPKAP kinase-I or calmod- 
ulin-dependent protein kinase-lI (data not shown), 
which both phosphorylate he peptide KKPLNRTLS- 
VASLPGLamide efficiently, were unable to phospho- 
rylate hsp25 or hsp27 at all when added at the same 
concentration (2 U/ml). 
3.2. Identification of the residues in hsp25 and hsp27 
phosphorylated byMAPKAP kinase-2 
hsp25 phosphorylated by MAPKAP kinase-2 was di- 
gested with trypsin and three major 32p-labelled pep- 
tides were resolved by chromatography on a Cls column 
(Fig. 2). Peptides la and lb had identical amino acid 
compositions and the sequence of peptide la was 
QLSSGVSEIR. The frst serine residue in this peptide, 
which corresponds to Ser ~6 in hsp25, was identified as 
the site of phosphorylation (Fig. 3A). Peptide l b did not 
yield any peptide sequence, indicating that its amino- 
terminus was blocked, presumably by cyclisation of the 
amino-terminal glutaminyl residue to a pyroglutaminyl 
residue. Its elution at a slightly higher concentration f
acetonitrile than peptide la (Fig. 2) is consistent with 
the loss of a positively charged amino group at the 
N-terminus, while peptide la could be partially con- 
verted to peptide 1 b by incubation at ambient tempera- 
ture in 1 M acetic acid (data not shown). Peptide 2a had 
the sequence SPSWEPFR and the second serine residue 
(Fig. 3), which corresponds to Ser 15 in hsp25, was iden- 
tified as the site of phosphorylation. Peptide 2b had the 
same amino acid sequence as peptide 2a. The reason for 
its elution at a slightly higher concentration f acetoni- 
trile is unclear, but it could either result from some 
modification of the tryptophan residue or isomerisation 
of one of the proline residues. Peptide 2c had the se- 
quence SPSWEPFRDWYPAHSR (data not shown) 
and resulted from incomplete cleavage of an Are-Asp 
peptide bond. The relative rates of phosphorylation f 
Ser ~ and Set 86 were calculated from the riP-radioactiv- 
ity associated with each tryptic phosphopeptide, and 
showed that Set B6 was labelled preferentially (Fig. IA). 
When 3-~P-labelled hsp 27 containing i.0 mol phosphate/ 
tool protein was digested with trypsin, four major ~-~P- 
peptides were resolved on the C~s column (Fig. 4~ lower 
trace). The peptides termed la and lb elutcd in the same 
positions as peptides I a and l b from the hsp 25 digest 
and their amino acid compositions (data not shown) 
and sequence (Fig. 3) demonstrated that they also corre- 
sponded to the unblocked and blocked forms of the 
peptide QLSSGVSEIR, these peptide sequences l~ing 
conserved between hsp25 and hsp27. The first serin¢ 
(Ser ~2 in hsp27) was identified as the site ofphosphoryl- 
ation (Fig. 3). Peptide 2a in the hsp27 digest had the 
sequence GPSWDPFR and the serine residue, which 
corresponds toSer ~5 of hsp27, was the site of phospho- 
rylation (Fig. 3). The sequence of peptide 2a in the 
hsp27 digest shows two conservative r placements from 
the corresponding peptide in the hsp25 digest. Peptide 
3 was a tetrapeptide with the sequence ALSR, the serine 
residue (corresponding to Ser TM of hsp27) being the site 
of phosphorylation (Fig. 3). This serine residue is re- 
placed by asparagine in hsp25, explaining why no a.~p. 
peptide corresponding to peptid¢ 3 is present in the 
tryptie digest of hsp25. 
Quantitative analysis of the 32P-labelled tryptic pep- 
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Fig, 3. Identification of the serine residues in hsp25 and hsp27 
phosphorylated by MAPKAP kinase-2. The 32P-labelled peptides in 
Figs, 2 and 4 were coupled covalently to an arylamine membrane and 
subj~ted to solid phase sequencintg on an Applied Biosystems 470A/ 
120A sequencer [1]. Conventional gas phase sequencing was also used 
to confirm the as~,ignmgnt of amino acid residues in the hsp25 pep- 
tides, The figure shows a-'P-radioactivity released and the amino acid 
residue identified (single letter code) after each cycle of Edman degra- 
dation. The full lines show the results obtained with peptidcs from 
hsp25 and the broken line results from the corresponding peptides of 
hsp27, In peptide 2a, the N-terminal residue is serine in hsp25 and 
rdycine in hsp27, and the lifth residue is ~zlutamic acid in lasp25 and 
aspartie acid in hsp27, a-'P-radioactivity (cpm) applied to sequencer 
was: 8,000 (peptide In, hsp25); 8,500 (peptid¢ In, hsp27); 13,000 (pep- 
tide 2a, hsp25); 8,000 (peptide 2a, hsp27); 17,000 (l~ptide 3, hsp27). 
tides at various times of phosphorylation revealed that 
Set ~2 in hsp27 is phosphorylated much faster than either 
Ser ~5 or $er 7~ (Fig. 1B). For example, after 15 min when 
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Fig, 4. Separation of  ~2P-labelled tryptic peptides from hsp27 by 
chromatography on a C~, column. The experiment was carried out in 
an identical manner to that described in Fig, 2 using the 15 rain (A) 
.'tad 135 rain (B) time points from the hsp27 phosphorylation reaction 
(Fig. IB). 
phosphorylation was only 0.2 mol/mol, about 90% of 
the phosphate was present in Set s~', 5% in Ser ~5 and 5% 
in Ser TM (Figs. 1B and 4A). 
3.3. Co-purification of hsp25 kinase activity with 
MA PKA P kinase.2 
We have developed a method for purifying 
MAPKAP kinase-2 to homogeneity from skeletal mus- 
cle by which the enzyme is purified 85,000-fold within 
3 days [1]. The procedure involves batchwise chroma- 
tography on CM-Sephadex, precipitation at 45% am- 
monium sulphate, chromatography on DEAE-cellu- 
lose, successive gradient elutions from S-Sepharose, 
Mono S and Mono Q and gel-filtration on Superose 12. 
The purified enzyme contains two components whose 
apparent molecular masses estimated by SDS/poly- 
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Fig. 5. Co.purification of hsp25 kinas¢ activity with MAPKAP kinase. 2 on S.Sepharos~, Mono S and Mono Q. MAPKAP kinasc-2 was assayed 
using the peptidc KKPLNRTLSVASLPGLamid¢ at 30/aM (closed circles) and hsp25 kinase using hsp25 at 6/xM (o~n circles). The broken lines 
denote the salt gradients. (A) The flowthrough lYactions from DEAE Cellulose were applied 1o a column of $-Sepharos¢ (10 x 1.6 gin) equilibrated 
at ambient emperature in 20 mM MOPS, pH 7.0, I mM EDTA, 5% (v/v) glycerol, 0.01% (w/v) Brij 35, 1 mM L~nzamidine and 0.1% (v/v) 
2.mcreaptocthanol (Buffer A), After washin~ with equilibration buffer until the absorbanee at280 nm was < 0.02, the colltmn was developed with 
a 200 ml linear salt gradient to 0.5 M NaCl in tile same buffer. The flow rate was 3 ml/min and fractions of 2.5 ml were collected. (B) The enzyme 
from S-Sepharose was dialysed for 90 min into Buffer A containing 50% (v/v) glycerol, then diluted 4-fold in Buffer A and applied to a Mono S 
column (5 × 0.5 era) equilibrated at ambient temperature in Buffer A. After washing with buffer until the absorban~ at 280 nm was < 0,02, the 
column was developed with a 40 ml linear salt gradient to 0.1 M M~CI~ in Buffer A. The '~,,,,0 . . . . . . .  ,,,,,. ";,'as ..~ n ..,......m"~: . . . .. . . .  I fmc~.ions of 0,5 ml were 
collected. (C) The enzyme from Mono S was dialysed against Buffer A and applied to a column of Mono Q (5 x 0.5 cm) equilibrated in ~;f:br 
A. After washing with 10 ml of buffer A, the column was developed with a 40 ml linear salt gradient to 0.3 M NaCI. The flow rate was 1.0 ml/min 
and fractions of 0,5 ml were collected. Further details of the preparation arc given in [ll, 
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Fig. 6. Expression or the small heat shock protein in rabbit skeletal 
muscle and its phosphorylation by MAPKAP kinase.2, Heat-inac- 
tivated extracts of rabbit skeletal muscle were incubated in the pre~- 
race of Mg[~-'-~-'PIATP with and without the addition of MAPKAP 
kinase-2 (Section 2). In two further eactions, purified marine hsp25 
was added to serve as an internal marker protein. After phosphoryla- 
tion, the small heat shock proteins were immtmoprecipitated with a 
specific antibody and the immunoprecipitates analysed by SDS/poly- 
acrylamide gel electrophorcsis. The figure zhows an autoradiograpb 
of the gel and molecular weight standards (MWS) are marked, 
acrylamide gel eleetrophoresis are 60 kDa and 53 kDa, 
respectively. These species have identical specific activi- 
ties and the amino acid sequences of six peptides iso- 
lated from each component were found to be identical, 
indicating that that they are either closely related 
isozymes or derived From the same gene [1]. 
hsp25 kinase activity co-purified with MAPKAP ki- 
nase-2 activity through batchwise chromatography on
CM-Sephadex and precipitation with ammonium 
sulphate, and like MAPKAP kinase.2 activit2~, all the 
hsp25 kinase activity did not bind to DF,.AE-cellulose 
equilibrated in 5 mM MOPS, pH 7.0 (data not shown). 
Like MAPKAP kinase-2 [1], the hsp25 kinase activity 
in the DEAE-cellulose luate (and at all subsequent 
steps) was completely inactivated by preineubation for 
30 mix with 5 mU/ml protein phosphatase 2A (see [24] 
for definition of units). After chromatography on 
DEAE.eellulose, hsp25 kinase activity exactly co-puri- 
fied with MAPKAP kinase-2 through successive chro- 
matographies on S-Sepharose, Mono S and Mono Q 
(Fig. 5). The partial resolution of MAPKAP kinase-2 
and hsp25 kinase activity into two components on 
Mono S (Fig. 5) is only observed occasionally and may 
reflect some separation &the 60 kDa and 53 kDa forms 
of the enzyme. When assayed with the standard• peptide 
substrate at 30 ]lM and hsp25 at 20 tiM, the activity 
ratio MAPKAP kinase-2/hsp25 kinase was 1.6 (after 
S-Sepharose), 1.6 (after Mono S) and 1.7 (after Mono 
Q), which compares to 1.8 in the muscle extract, 2.2 in 
the CM-Sephadex eluate and 1.7 for homogeneous 
preparations of MAPKAP kinase-2 purified through 
the final gel-filtration step. 
About 30% of the protein kinase activity in muscle 
extracts measured with either hsp25 or the standard 
peptide substrate was not retained by CM-Sephadex. 
The peptide kinase activity not retained by this cationic 
exchange resin is distinct from MAPKAP kinase-2, be- 
cause it is eluted from Mono Q at a far higher concen- 
tration of NaCI (0.4 M) and is not inactivated by pro- 
tein phosphatase-2A. This protein kinase is devoid of 
hsp25 kinase activity and indeed no protein kinase with 
significant activity towards hsp25 was detected when 
the Mono Q fractions were assayed with this substrate. 
It is possible that the hsp25 kinase activity in the CM- 
Sephadex flowthrough fractions is the summation of 
many protein kinases each of which has trace hsp25 
kinase activity. 
Although small heat shock proteins have been identi. 
fled in a wide variety of mammalian tissues, they had 
not been identified previously in rabbit skeletal muscle 
from which MAPKAP kinase-2 is purified. In order to 
demonstrate the biological relevance of the phosphoryl. 
ation reaction, it was therefore important to show that 
this small shock protein was present in skeletal muscle 
and that it could be phosphoryl,'tted by MAPKAP ki- 
rinse-2. Heat-treated muscle extracts were therefore in- 
cubated with MAPKAP kinase-2 and Mg[~'JaP]ATP 
and subjected to immunopreeipitation using an antise- 
rum against an hsp25/hsp27 hybrid protein [25] as de- 
scribed in Section 2. Analysis by SDS/polyacrylamide 
gel electrophoresis clearly revealed that a single 
phosphoprotein had been immunoprecipitated from the 
extracts which co-migrated with hsp25 (Fig. 6). 
4. DISCUSSION 
In this paper we have demonstrated that the small 
mammalian heat shock proteins are phosphorylated by
MAPKAP kinase-2 at similar ates to the synthetic pep- 
tide KKPLNRTLSVASLPGLamide which is the stand- 
ard substrate used to assay this enzyme. Since the V,,o~ 
towards this peptide (about 5/.tmols/min/mg) is com- 
parable to that of other protein serine/threonine kinases 
towards their best substrates, hsp25 and hsp27 are 
clearly good substrates for MAPKAP kinase-2. The 
high degree of specificity of MAPKAP kinase-2 for 
these small heat shock proteins is emphasized by the 
failure of two other protein kinases (MAPKAP kinase-I 
[26] and calmodulin-dependent protein kinase-II [27], 
that phosphorylate Arg-Xaa-Xaa-Ser motifs, to phos- 
phorylate hsp25 or hsp27 at all. The importance of' 
MAPKAP kinase-2 in the phosphorylation of hsp25 
~,-,H hsp27 ;- ,,;vo ;~ ~,,~-'~'~ h,, ~h,-,.,, r ,,.,h,~,, findings. 
Firstly, under our assay conditions, hsp25 kinase activ- 
ity and MAPKAP kinase-2 activity eo-purlf.v through- 
out the isolation procedure for the latter enzyme. Sec- 
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ondly MAPKAP kinase-2 and the substrate small heat 
shock protein are co-expressed in rabbit skeletal muscle. 
Thirdly, the residues on hsp25 and hsp27 
phosphorylated by MAPKAP kinase-2 in vitro are the 
same as those reported to be phosphorylated in intact 
ceils. In mouse Ehrlieh ascites tumour ceils Set ~6 was 
shown to be the major site of in vivo phosphorylation 
and Ser ~ the minor site [18]. In chinese hamster ovary 
cells, human HeLa ceils and human mammary tumour 
cell line MCF-7, the major site of phosphorylation was 
Set ~2 while Ser 78 was phosphorylated to a lesser extent. 
More minor phosphorylation of Ser ~s also appeared to 
take place, although this was not established efinitively 
[8]. The relative amounts of phosphate present in each 
site in vivo are consistent with their relative rates of 
phosphorylation by MAPKAP kinase-2 in vitro. It is 
well established that certain heat shock conditions in- 
crease the phosphorylation of the small heat shock pro- 
teins in vivo [11-13] and our results now suggest that 
this is explained by increased activity of MAPKAP ki- 
rinse-2 which is itself activated by the beat shock.induc- 
ible MAP kinase activity [17]. 
Under our assay conditions cyclic AMP.dependent 
protein kinase is inhibited by the inclusion of its specific 
peptide inhibitor and calcium-dependent protein ki- 
nases (such as protein kinase C) by the inclusion of 
EGTA. Cyclic AMP-dependent protein kinase and pro- 
tein kinase C are both capable of phosphorylating 
hsp25 in vitro at Ser ~s and Ser s6, albeit with low effi- 
ciency [18], but it is unlikely that either enzyme phos- 
phorylates hsp25 in vivo for several reasons. Firstly, 
cyclic AMP-elevating agonists do not appear to stimu- 
late the phosphorylation of hsp25 [7]. Secondly, deple- 
tion of protein kinase C by prolonged treatment of cells 
with phorbol myristate acetate has no effect on the 
phosphorylation of hsp25 induced by turnout necrosis 
factor or intedeukin-1 [7]., 
It has recently been shown that the small heat shock 
proteins have chaperone-like properties in vitro [22]. As 
also found for hsp90 [28], these chaperone-like proper- 
ties are not influenced by the addition of ATP and the 
release of proteins bound to the heat shock proteins is 
not accompanied by ATP depletion. It will, however, 
clearly be of interest o examine whether the chaperone- 
like properties of these proteins are regulated by their 
degree of phosphorylation. Since phosphorylation of 
the small heat shock proteins is catalysed by MAPKAP 
kinase-2 and one of the enzymes which is capable of 
dephosphorylating these proteins is the calcium-de- 
pendent protein phosphatase 2B [29], this raises the 
intriguing possibility that intracellular chaperoning is 
regulated by at least two cellular signal transduction 
systems. 
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